123 related articles for article (PubMed ID: 29618495)
1. Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.
Mohan D; Forman JR; Allinder M; McEniery CM; Bolton CE; Cockcroft JR; MacNee W; Fuld J; Marchong M; Gale NS; Fisk M; Nagarajan S; Cheriyan J; Lomas DA; Calverley PMA; Miller BE; Tal-Singer R; Wilkinson IB; Polkey MI;
Thorax; 2018 Dec; 73(12):1182-1185. PubMed ID: 29618495
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the role of inflammation in chronic airways disease: the ERICA study.
Mohan D; Gale NS; McEniery CM; Bolton CE; Cockcroft JR; MacNee W; Fuld J; Lomas DA; Calverley PM; Shale DJ; Miller BE; Wilkinson IB; Tal-Singer R; Polkey MI;
COPD; 2014 Sep; 11(5):552-9. PubMed ID: 24832197
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance is associated with skeletal muscle weakness in COPD.
Wells CE; Polkey MI; Baker EH
Respirology; 2016 May; 21(4):689-96. PubMed ID: 26678022
[TBL] [Abstract][Full Text] [Related]
4. Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease.
Fisk M; Cheriyan J; Mohan D; McEniery CM; Forman J; Cockcroft JR; Rudd JHF; Tal-Singer R; Hopkinson NS; Polkey MI; Wilkinson IB
Respir Res; 2018 May; 19(1):100. PubMed ID: 29793484
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities.
Sharanya A; Ciano M; Withana S; Kemp PR; Polkey MI; Sathyapala SA
Chron Respir Dis; 2019; 16():1479973119843650. PubMed ID: 31131626
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
Patel AR; Kowlessar BS; Donaldson GC; Mackay AJ; Singh R; George SN; Garcha DS; Wedzicha JA; Hurst JR
Am J Respir Crit Care Med; 2013 Nov; 188(9):1091-9. PubMed ID: 24033321
[TBL] [Abstract][Full Text] [Related]
7. Increased skeletal muscle-specific microRNA in the blood of patients with COPD.
Donaldson A; Natanek SA; Lewis A; Man WD; Hopkinson NS; Polkey MI; Kemp PR
Thorax; 2013 Dec; 68(12):1140-9. PubMed ID: 23814167
[TBL] [Abstract][Full Text] [Related]
8. Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation.
Vanfleteren LE; Spruit MA; Groenen MT; Bruijnzeel PL; Taib Z; Rutten EP; Op 't Roodt J; Akkermans MA; Wouters EF; Franssen FM
Eur Respir J; 2014 May; 43(5):1306-15. PubMed ID: 24311762
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity.
Kharbanda S; Ramakrishna A; Krishnan S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1727-35. PubMed ID: 26366065
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of the quadriceps strength in patients with chronic obstructive pulmonary disease].
Ju CR; Chen RC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):566-70. PubMed ID: 19080397
[TBL] [Abstract][Full Text] [Related]
11. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease.
Van Vliet M; Spruit MA; Verleden G; Kasran A; Van Herck E; Pitta F; Bouillon R; Decramer M
Am J Respir Crit Care Med; 2005 Nov; 172(9):1105-11. PubMed ID: 16100014
[TBL] [Abstract][Full Text] [Related]
12. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients.
Ferrari R; Caram LM; Faganello MM; Sanchez FF; Tanni SE; Godoy I
Int J Chron Obstruct Pulmon Dis; 2015; 10():1553-8. PubMed ID: 26345641
[TBL] [Abstract][Full Text] [Related]
13. Specific motor cortex hypoexcitability and hypoactivation in COPD patients with peripheral muscle weakness.
Alexandre F; Héraud N; Tremey E; Oliver N; Bourgouin D; Varray A
BMC Pulm Med; 2020 Jan; 20(1):1. PubMed ID: 31900129
[TBL] [Abstract][Full Text] [Related]
14. Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study.
Gale NS; Albarrati AM; Munnery MM; Mcdonnell BJ; Benson VS; Singer RMT; Cockcroft JR; Shale DJ
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987061
[No Abstract] [Full Text] [Related]
15. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD.
Seymour JM; Ward K; Sidhu PS; Puthucheary Z; Steier J; Jolley CJ; Rafferty G; Polkey MI; Moxham J
Thorax; 2009 May; 64(5):418-23. PubMed ID: 19158125
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.
Shrikrishna D; Tanner RJ; Lee JY; Natanek A; Lewis A; Murphy PB; Hart N; Moxham J; Montgomery HE; Kemp PR; Polkey MI; Hopkinson NS
Chest; 2014 Oct; 146(4):932-940. PubMed ID: 24556825
[TBL] [Abstract][Full Text] [Related]
17. Distal leg muscle function in patients with COPD.
Gagnon P; Maltais F; Bouyer L; Ribeiro F; Coats V; Brouillard C; Noël M; Rousseau-Gagnon M; Saey D
COPD; 2013 Apr; 10(2):235-42. PubMed ID: 23547635
[TBL] [Abstract][Full Text] [Related]
18. Quadriceps muscle strength in scoliosis.
Swallow EB; Barreiro E; Gosker H; Sathyapala SA; Sanchez F; Hopkinson NS; Moxham J; Schols A; Gea J; Polkey MI;
Eur Respir J; 2009 Dec; 34(6):1429-35. PubMed ID: 19443534
[TBL] [Abstract][Full Text] [Related]
19. Relevance of assessing quadriceps endurance in patients with COPD.
Coronell C; Orozco-Levi M; Méndez R; Ramírez-Sarmiento A; Gáldiz JB; Gea J
Eur Respir J; 2004 Jul; 24(1):129-36. PubMed ID: 15293615
[TBL] [Abstract][Full Text] [Related]
20. Quadriceps wasting and physical inactivity in patients with COPD.
Shrikrishna D; Patel M; Tanner RJ; Seymour JM; Connolly BA; Puthucheary ZA; Walsh SL; Bloch SA; Sidhu PS; Hart N; Kemp PR; Moxham J; Polkey MI; Hopkinson NS
Eur Respir J; 2012 Nov; 40(5):1115-22. PubMed ID: 22362854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
